• Sciascia S, Radin M, Cecchi I, Levy RA, Erkan D. 16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome. Lupus. 2021;30(8):1314–26. https://doi.org/10.1177/09612033211020361. Most recent guideline report on clinical manifestations of APS from the 16thth International congress on antiphospholipid antibodies task force.

CAS  Article  PubMed  Google Scholar 

Xourgia E, Tektonidou MG. An update on antiphospholipid syndrome. Curr Rheumatol Rep. 2022;23(12):84. https://doi.org/10.1007/s11926-021-01051-5.

CAS  Article  PubMed  Google Scholar 

Duarte-Garcia A, Pham MM, Crowson CS, Amin S, Moder KG, Pruthi RK, et al. The epidemiology of antiphospholipid syndrome: a population-based study. Arthritis Rheumatol. 2019;71(9):1545–52. https://doi.org/10.1002/art.40901.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Radin M, Sciascia S, Bazzan M, Bertero T, Carignola R, Montabone E, et al. Antiphospholipid syndrome is still a rare disease-estimated prevalence in the Piedmont and Aosta Valley Regions of Northwest Italy: comment on the article by Duarte-Garcia et al. Rheumatol. 2020;72(10):1774–6. https://doi.org/10.1002/art.41401.

Article  Google Scholar 

Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306. https://doi.org/10.1111/j.1538-7836.2006.01753.x.

CAS  Article  PubMed  Google Scholar 

Rato IR, Barbosa AR, Afonso DJ, Beca S. Catastrophic antiphospholipid syndrome presented as ruptured papillary muscle during puerperium in a patient with systemic lupus erythematosus. Lupus. 2021;30(6):1017–21. https://doi.org/10.1177/09612033211002273.

CAS  Article  PubMed  Google Scholar 

•• Asherson RA, Cervera R. Catastrophic antiphospholipid syndrome. Curr Rheumatol Rep. 2003;5(5):395–400. https://doi.org/10.1007/s11926-003-0031-7. Seminal description of CAPS and proposed preliminary classification criteria.

Article  PubMed  Google Scholar 

Asherson RA, Cervera R. The antiphospholipid syndrome: multiple faces beyond the classical presentation. Autoimmun Rev. 2003;2(3):140–51. https://doi.org/10.1016/s1568-9972(02)00147-7.

Article  PubMed  Google Scholar 

Asherson RA, Cervera R, de Groot PG, Erkan D, Boffa MC, Piette JC, et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus. 2003;12(7):530–4. https://doi.org/10.1191/0961203303lu394oa.

CAS  Article  PubMed  Google Scholar 

Erkan D, Cervera R, Asherson RA. Catastrophic antiphospholipid syndrome: where do we stand? Arthritis Rheum. 2003;48(12):3320–7. https://doi.org/10.1002/art.11359.

Article  PubMed  Google Scholar 

•• Cervera R, Rodriguez-Pinto I, Legault K, Erkan D. 16th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome. Lupus. 2020;29(12):1594–600. https://doi.org/10.1177/0961203320951260. Most recent guideline report on CAPS from the 16thth International congress on antiphospholipid antibodies task force.

Article  PubMed  Google Scholar 

Cervera R, Rodriguez-Pinto I, Espinosa G. The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: a comprehensive review. J Autoimmun. 2018;92:1–11. https://doi.org/10.1016/j.jaut.2018.05.007.

Article  PubMed  Google Scholar 

Lim W. Antiphospholipid antibody syndrome. Hematology Am Soc Hematol Educ Program. 2009:233–9. https://doi.org/10.1182/asheducation-2009.1.233

Ricarte IF, Dutra LA, Abrantes FF, Toso FF, Barsottini OGP, Silva GS, et al. Neurologic manifestations of antiphospholipid syndrome. Lupus. 2018;27(9):1404–14. https://doi.org/10.1177/0961203318776110.

CAS  Article  PubMed  Google Scholar 

Man YL, Sanna G. Neuropsychiatric manifestations of antiphospholipid syndrome-a narrative review. Brain Sci. 2022;12(1). https://doi.org/10.3390/brainsci12010091

Arnson Y, Shoenfeld Y, Alon E, Amital H. The antiphospholipid syndrome as a neurological disease. Semin Arthritis Rheum. 2010;40(2):97–108. https://doi.org/10.1016/j.semarthrit.2009.05.001.

CAS  Article  PubMed  Google Scholar 

• Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46(4):1019–27. https://doi.org/10.1002/art.10187. The Euro-Phospholipid Project Group Study highlighting 1000 patients with APS and detailed prevalence of various neurologic and non-neurologic clinical manifestations.

Article  PubMed  Google Scholar 

Cervera R, Serrano R, Pons-Estel GJ, Ceberio-Hualde L, Shoenfeld Y, de Ramon E, et al. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis. 2015;74(6):1011–8. https://doi.org/10.1136/annrheumdis-2013-204838.

CAS  Article  PubMed  Google Scholar 

• Garcia-Grimshaw M, Posadas-Pinto DR, Jimenez-Ruiz A, Valdes-Ferrer SI, Cadena-Fernandez A, Torres-Ruiz JJ, et al. Antiphospholipid syndrome-mediated acute cerebrovascular diseases and long-term outcomes. Lupus. 2022;31(2):228–37. https://doi.org/10.1177/09612033221074178. A recent retrospective cohort study describing the spectrum of cerebrovascular disease among patients with APS.

CAS  Article  PubMed  Google Scholar 

Valdes-Ferrer SI, Vega F, Cantu-Brito C, Ceballos-Ceballos J, Estanol B, Garcia-Ramos G, et al. Cerebral changes in SLE with or without antiphospholipid syndrome a case-control MRI study. J Neuroimaging. 2008;18(1):62–5. https://doi.org/10.1111/j.1552-6569.2007.00183.x.

Article  PubMed  Google Scholar 

Fleetwood T, Cantello R, Comi C. Antiphospholipid syndrome and the neurologist: from pathogenesis to therapy. Front Neurol. 2018;9:1001. https://doi.org/10.3389/fneur.2018.01001.

Article  PubMed  PubMed Central  Google Scholar 

Rodrigues CE, Carvalho JF, Shoenfeld Y. Neurological manifestations of antiphospholipid syndrome. Eur J Clin Invest. 2010;40(4):350–9. https://doi.org/10.1111/j.1365-2362.2010.02263.x.

Article  PubMed  Google Scholar 

Hughes GR. Migraine, memory loss, and “multiple sclerosis” Neurological features of the antiphospholipid (Hughes’) syndrome. Postgrad Med J. 2003;79(928):81–3. https://doi.org/10.1136/pmj.79.928.81.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Sciascia S, Sanna G, Khamashta MA, Cuadrado MJ, Erkan D, Andreoli L, et al. The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review. Ann Rheum Dis. 2015;74(11):2028–33. https://doi.org/10.1136/annrheumdis-2014-205663.

CAS  Article  PubMed  Google Scholar 

Provenzale JM, Barboriak DP, Allen NB, Ortel TL. Patients with antiphospholipid antibodies: CT and MR findings of the brain. AJR Am J Roentgenol. 1996;167(6):1573–8. https://doi.org/10.2214/ajr.167.6.8956600.

CAS  Article  PubMed  Google Scholar 

de Amorim LC, Maia FM, Rodrigues CE. Stroke in systemic lupus erythematosus and antiphospholipid syndrome: risk factors, clinical manifestations, neuroimaging, and treatment. Lupus. 2017;26(5):529–36. https://doi.org/10.1177/0961203316688784.

CAS  Article  PubMed  Google Scholar 

Silvis SM, de Sousa DA, Ferro JM, Coutinho JM. Cerebral venous thrombosis. Nat Rev Neurol. 2017;13(9):555–65. https://doi.org/10.1038/nrneurol.2017.104.

Article  PubMed  Google Scholar 

Burch R, Rizzoli P, Loder E. The prevalence and impact of migraine and severe headache in the United States: updated age, sex, and socioeconomic-specific estimates from government health surveys. Headache. 2021;61(1):60–8. https://doi.org/10.1111/head.14024.

Article  PubMed  Google Scholar 

Cavestro C, Micca G, Molinari F, Bazzan M, DIP C, Aloi R, et al. Migraineurs show a high prevalence of antiphospholipid antibodies. J Thromb Haemost. 2011;9(7):1350–4. https://doi.org/10.1111/j.1538-7836.2011.04348.x.

CAS  Article  PubMed  Google Scholar 

Cavestro C, Degan D, Micca G, Aloi R, Mandrino S, Frigeri MC, et al. Thrombophilic alterations, migraine, and vascular disease: results from a case-control study. Neurol Sci. 2021;42(9):3821–8. https://doi.org/10.1007/s10072-020-05006-z.

Article  PubMed  Google Scholar 

Schofield JR, Hughes HN, Birlea M, Hassell KL. A trial of antithrombotic therapy in patients with refractory migraine and antiphospholipid antibodies: a retrospective study of 75 patients. Lupus. 2021;30(4):568–77. https://doi.org/10.1177/0961203320983913.

Article  PubMed  Google Scholar 

de Carvalho JF, Pasoto SG, Appenzeller S. Seizures in primary antiphospholipid syndrome: the relevance of smoking to stroke. Clin Dev Immunol. 2012;2012: 981519. https://doi.org/10.1155/2012/981519.

Article  PubMed  PubMed Central  Google Scholar 

Shoenfeld Y, Lev S, Blatt I, Blank M, Font J, von Landenberg P, et al. Features associated with epilepsy in the antiphospholipid syndrome. J Rheumatol. 2004;31(7):1344–8.

PubMed  Google Scholar 

Noureldine MH, Harifi G, Berjawi A, Haydar AA, Nader M, Elnawar R, et al. Hughes syndrome and epilepsy: when to test for antiphospholipid antibodies? Lupus. 2016;25(13):1397–411. https://doi.org/10.1177/0961203316651747.

CAS  Article  PubMed  Google Scholar 

Cimaz R, Guerrini R. Epilepsy in lupus. Lupus. 2008;17(9):777–9. https://doi.org/10.1177/0961203308094362.

Article  PubMed  Google Scholar 

Rosati A, Guerrini R, Cimaz R. Lupus, antiphospholipid syndrome and epilepsy: an update. Lupus. 2017;26(1):3–5. https://doi.org/10.1177/0961203316666961.

CAS  Article  PubMed  Google Scholar 

Yelnik CM, Kozora E, Appenzeller S. Non-stroke central neurologic manifestations in antiphospholipid syndrome. Curr Rheumatol Rep. 2016;18(2):11. https://doi.org/10.1007/s11926-016-0568-x.

CAS  Article  PubMed  Google Scholar 

Brey RL, Muscal E, Chapman J. Antiphospholipid antibodies and the brain: a consensus report. Lupus. 2011;20(2):153–7. https://doi.org/10.1177/0961203310396748.

CAS  Article  PubMed  Google Scholar 

Cervera R, Boffa MC, Khamashta MA, Hughes GR. The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe. Lupus. 2009;18(10):889–93. https://doi.org/10.1177/0961203309106832.

CAS